24 Hours Treatment with Alteplase in Patients with Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 372 participants.
Also called NCT04879615
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 372 participants
- Registry
-
NCT04879615
-
- Other papers using this trial's data
- Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: The HOPE Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04879615. Randomized; single masking; primary purpose treatment. Start 2021-06-21 (actual); primary completion 2024-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- 24 Hours Treatment with Alteplase in Patients with Ischemic Stroke
- Condition
- Stroke
- Intervention (Drug)
- Alteplase
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct04879615- Content hash
266e28eda1c825f1e2a8cc3bf91e4d9ab993da4d97ed8190737c925fd512fc2d